Literature DB >> 34035759

Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.

Sheena Crosby1, Michael J Schuh1, Freddy Caldera2, Francis A Farraye3.   

Abstract

Inflammatory bowel disease and the subsequent immunosuppressive regimens used to treat this condition increase the risk for acquiring viral and bacterial infections. Ensuring that patients are up-to-date with their immunizations may help prevent the development of several of these vaccine-preventable diseases. Therefore, it is imperative that gastroenterology providers offer vaccinations to patients or direct vaccination guidance to primary care providers to minimize the risk for vaccine-preventable diseases. To decrease the risk for co-infection in the setting of the coronavirus disease 2019 pandemic and avoid placing any further burden on the health care system, the call to immunize is more important than ever.
Copyright © 2021, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  COVID-19; Crohn’s disease; Vaccines; inflammatory bowel disease; preventive care; ulcerative colitis

Year:  2021        PMID: 34035759      PMCID: PMC8132679     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  64 in total

1.  Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis.

Authors:  Douglas L Nguyen; Emily T Nguyen; Matthew L Bechtold
Journal:  Dig Dis Sci       Date:  2015-03-22       Impact factor: 3.199

2.  Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.

Authors:  Nabeel Khan; Dhruvan Patel; Chinmay Trivedi; Yash Shah; Gary Lichtenstein; James Lewis; Yu-Xiao Yang
Journal:  Clin Gastroenterol Hepatol       Date:  2018-01-05       Impact factor: 11.382

3.  Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

Authors:  Carlos A DiazGranados; Andrew J Dunning; Murray Kimmel; Daniel Kirby; John Treanor; Avi Collins; Richard Pollak; Janet Christoff; John Earl; Victoria Landolfi; Earl Martin; Sanjay Gurunathan; Richard Nathan; David P Greenberg; Nadia G Tornieporth; Michael D Decker; H Keipp Talbot
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

4.  Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.

Authors:  Nabeel Khan; Chinmay Trivedi; Himanshu Kavani; James Lewis; Yu-Xiao Yang
Journal:  Inflamm Bowel Dis       Date:  2019-01-10       Impact factor: 5.325

5.  Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy.

Authors:  Ying Lu; Athos Bousvaros
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-06

6.  Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.

Authors:  M Esteve; C Saro; F González-Huix; F Suarez; M Forné; J M Viver
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

7.  Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.

Authors:  Venkata R Satyam; Pei-Hsuan Li; Jason Reich; Taha Qazi; Ansu Noronha; Sharmeel K Wasan; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2020-01-02       Impact factor: 3.199

8.  Optimizing Immunization Strategies in Patients with IBD.

Authors:  Freddy Caldera; Dana Ley; Mary S Hayney; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2021-01-01       Impact factor: 5.325

9.  High-risk human papilloma virus infection and cervical neoplasm in female inflammatory bowel disease patients: a cross-sectional study.

Authors:  Miao Li; Qing-Fan Yang; Qian Cao; Jian Tang; Yu Gao; Min Zhi; Kang Chao; Ming-Li Su; Wei-Min Huang; Yan Yi; Sui-Yan Xia; Ling-Jie Huang; Yuan Zhao; Xiao-Hong Wang; Xiao-Ying Liu; Lin Lin; Pin-Jin Hu; Xiang Gao
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-02-15
View more
  2 in total

1.  SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID.

Authors:  Yoo Jin Lee; Seong-Eun Kim; Yong Eun Park; Ji Young Chang; Hyun Joo Song; Duk Hwan Kim; Young Joo Yang; Byung Chang Kim; Jae Gon Lee; Hee Chan Yang; Miyoung Choi; Seung-Jae Myung
Journal:  Intest Res       Date:  2022-01-05

Review 2.  Vaccination strategies for Korean patients with inflammatory bowel disease.

Authors:  Yoo Jin Lee; Eun Soo Kim
Journal:  Korean J Intern Med       Date:  2022-08-08       Impact factor: 3.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.